• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ASAHI KASEI MEDICAL CO., LTD. ASAHI REXEED-S SERIES DIALYZERS; DIALYZER, HIGH PERMEABILITY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ASAHI KASEI MEDICAL CO., LTD. ASAHI REXEED-S SERIES DIALYZERS; DIALYZER, HIGH PERMEABILITY Back to Search Results
Model Number APS-18SA
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Low Blood Pressure/ Hypotension (1914); Shock (2072)
Event Date 11/16/2020
Event Type  Injury  
Manufacturer Narrative
The product of this event was not returned to the manufacturer and could not be analyzed; however we investigated manufacturing and quality control records based on the lot number.According to the investigation, no potential for malfunction was found.(b)(4) pieces of lot ak797g were manufactured, and no similar event has been reported with this lot number globally so far.We also reported this incident separately on mfr report number 3007340888-2020-00050.The physician determined, this event as serious.The physician also commented that this event seems to be an allergic response to the membrane material used for product, because the patient is allergic to cats, and the eosinophil value and ige value were both high, as well as the adverse events occured from the sixth time of product use.We considered, this event as "serious" because the patient's systolic blood pressure was decreased to 55 mmhg from 133 mmhg after 20 minutes of the treatment and went into shock.Also, the patient was discontinued the treatment since he did not improve after administering sodium chloride and oxygen, and the physician judged as "serious".The event occurred 20 minutes after the initiation of the treatment.Therefore, a causal relationship could no be denied.In adverse reactions in ifu of rexeed-s, it is described as "patients with a history of hypersensitivity reactions or those prone to hypersensitivity should be carefully monitored by the physician.It is recommended that, based on the physicians directions, treatment should be discontinued if signs or symptoms of hypersensitivity are exhibited." and "side effects such as hypertension, hypotension, headache, and nausea that may be associated with hypovolemia or hypervolemia can usually be avoided by careful management of the patient's fluid, electrolyte balance, blood flow rate, and transmembrane pressure (tmp)." we will continue to monitor the occurrence of similar events carefully.
 
Event Description
This incident occurred in (b)(6).Aps-sa series is identical model to rexeed-s series marketed in us.On november 16, the patient's systolic blood pressure, which was 133 mmhg at the beginning of treatment, decreased to 55 mmhg 20 minutes after the start of treatment.He complained of difficulty breathing and went into shock.Fluid removal was immediately stopped, and sodium chloride 100 ml and oxygen were administered.Three minutes later, sodium chloride 100 ml was added and the systolic blood pressure increased to 78 mmhg.Two minutes later, the treatment was stopped and blood was returned since the patient still complained of difficulty breathing even though the oxygen administration was increased.Twelve minutes after completing the blood return, the systolic blood pressure recovered to 100 mmhg.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ASAHI REXEED-S SERIES DIALYZERS
Type of Device
DIALYZER, HIGH PERMEABILITY
Manufacturer (Section D)
ASAHI KASEI MEDICAL CO., LTD.
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0 006
JA  100-0006
Manufacturer (Section G)
ASAHI KASEI MEDICAL MT CORP. OKATOMI PLANT
5-4960
nakagawara-machi
nobeoka-shi, 882-0 031
JA   882-0031
Manufacturer Contact
naomi kagami
1-1-2 yurakucho
chiyoda-ku
tokyo, 100-0-006
JA   100-0006
MDR Report Key11051975
MDR Text Key223135099
Report Number3007340888-2020-00040
Device Sequence Number1
Product Code KDI
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K153344
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional
Reporter Occupation Physician
Type of Report Initial
Report Date 11/24/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date07/31/2023
Device Model NumberAPS-18SA
Device Catalogue NumberN/A
Device Lot NumberAK797G
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 11/24/2020
Initial Date FDA Received12/21/2020
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/17/2020
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Treatment
NIKKISO DBB-27
Patient Outcome(s) Other;
Patient Age50 YR
Patient Weight86
-
-